Etoricoxib Induced Toxic Epidermal Necrolysis: A Case Report

Published on:January 2024
Indian Journal of Pharmacy Practice, 2024; 17(1):89-92
Case Report | doi:10.5530/ijopp.17.1.15


Etoricoxib Induced Toxic Epidermal Necrolysis: A Case Report


Authors and affiliation (s):

Saba Farooqui1,*, Zuha Shyma1 , Suha Zulekha1, Jacintha Martis, Adarsh V V1

1Department of Pharmacy Practice, Karavali College of Pharmacy, Vamanjoor, Mangalore, Karnataka, INDIA. 

2Department of Dermatology, Father Muller Medical College Hospital, Mangalore, Karnataka, INDIA.

Abstract:

Toxic Epidermal Necrolysis (TEN) is a rare and life-threatening skin reaction that can quickly lead to dehydration and infection. TEN is perhaps the most formidable disease encountered by dermatologists, and it remains as puzzling a disorder as it was when described by Lyell. Etoricoxib is a medication that has been associated with TEN. The ideal medical management of TEN should be multidisciplinary and requires early diagnosis and withdrawal of suspected/causative drug(s), supportive care, and specific therapy. Here we present a case of Toxic Epidermal Necrolysis due to Etoricoxib in an immune-compromised patient.

Keywords: Case Report, Etoricoxib, Toxic epidermal necrolysis




 

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmacy Practice (IJOPP) [ISSN-0974-8326] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 2008.

DOI HISTORY

IJOPP uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2014 are being assigned DOIs for its permanent URLs